The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Implications of rapidity of response to initial therapy in multiple myeloma.
Krishna Bilas Ghimire
No relevant relationships to disclose
Vincent Rajkumar
No relevant relationships to disclose
Angela Dispenzieri
No relevant relationships to disclose
Martha Lacy
No relevant relationships to disclose
Morie Gertz
No relevant relationships to disclose
Francis Buadi
No relevant relationships to disclose
David Dingli
No relevant relationships to disclose
Suzanne R. Hayman
No relevant relationships to disclose
Nelson Leung
No relevant relationships to disclose
Stephen Russell
No relevant relationships to disclose
John Anthony Lust
No relevant relationships to disclose
Steven R. Zeldenrust
No relevant relationships to disclose
Yi Lin
No relevant relationships to disclose
Prashant Kapoor
No relevant relationships to disclose
Arleigh Robertson McCurdy
No relevant relationships to disclose
Robert A. Kyle
No relevant relationships to disclose
Shaji Kumar
No relevant relationships to disclose